NUSAP1 as a Novel Diagnostic Biomarker for High-Grade Endometrial Stromal Sarcoma
China National GeneBank DataBase · 01.01.2025
DOI: 10.26036/cnp0007981 ↗Kurz gefasst
Fachartikel in der Zeitschrift China National GeneBank DataBase, erschienen am 01.01.2025. Verfasst von Yanming Tan.
Abstract (Originalsprache)
NUSAP1 is a novel immunohistochemical marker with high specificity, which can be used for the differential diagnosis of High-grade endometrial stromal sarcoma (HGESS) versus low-grade endometrial stromal sarcoma (LGESS) and other uterine spindle cell tumors. Its diagnostic efficacy is significantly superior to that of CENPE, and it serves as an important complement to existing markers such as Cyclin D1 and BCOR, providing a new practical tool for the precise pathological diagnosis of HGESS.
Schlagwörter
Zitieren
APA
Tan, Y. (2025). NUSAP1 as a Novel Diagnostic Biomarker for High-Grade Endometrial Stromal Sarcoma. China National GeneBank DataBase. https://doi.org/10.26036/cnp0007981
Vancouver
Tan Y. NUSAP1 as a Novel Diagnostic Biomarker for High-Grade Endometrial Stromal Sarcoma. China National GeneBank DataBase. 2025. doi:10.26036/cnp0007981
BibTeX
@article{Tan2025,
author = {Tan, Yanming},
title = {NUSAP1 as a Novel Diagnostic Biomarker for High-Grade Endometrial Stromal Sarcoma},
journal = {China National GeneBank DataBase},
year = {2025},
doi = {10.26036/cnp0007981}
}
EUVIMED